18 hrs ago
Chinese firm imported misbranded API into US, says FDA warning letter
An inspection by the US Food and Drug Administration in October last year of Zhejiang's API facility in Taizhou, China led to a warning letter being issued earlier this month citing a number of cGMP and misbranding violations.
XenoPort to Release Second Quarter Financial Results on August 6, 2014
XenoPort, Inc. announced today that it will release its second quarter financial results on August 6, 2014 at approximately 4:30 p.m. Eastern Time.
GSP: Driver in 5-fatality wreck was on meth
The Gainesville woman driving the SUV in which five people were killed in Hall County on June 30 had drugs in her system at the time of the crash.
Depomed Announces District Court Order in ANDA Litigation
Depomed, Inc. today announced that on July 17, 2014, Judge Joel A. Pisano of the United States District Court for the District of New Jersey entered an order preliminarily enjoining Actavis Elizabeth LLC and Actavis Inc. from marketing a generic version of Gralise prior to the Court's issuance of an opinion in the matter.
Bulk ingredient prices skyrocket in US as payers clamp down
Bulk pharmaceutical ingredients increasingly used by compounding pharmacies have seen astronomical price hikes over the past two years and now payers are catching on to the trend and stepping in.